Tablets are very popular in a pharmaceutical dosage form. Tablet preparations can be made in various ways, including by direct compression methods, wet granulation, dry granulation, fast melt granulation, and foam granulation. Each of these methods has advantages and disadvantages. The direct compression methods have the advantages of a fast process that only requires mixing and compressing. Not all active ingredients can be directly compressed because they have a weakness in the flow properties and less compressible. The direct compression process requires additional materials or excipients called filler-binders. This review article will discuss the development of excipients for the manufacture of tablets by direct compression. At present, there are many excipients for direct compression in the market, with various advantages. The excipient is a co-processed material developed from the original material which cannot be used for direct compression excipients. Various co-processing that is done at the end will produce new materials that have better properties. With the availability of various types of direct compression excipients, the formulator has a variety of choices to be applied in the formulas designed. This will provide flexibility in selecting excipients to be applied to various active substances so that they will produce a dosage form with good quality.
Amol,. M., Bhairav, B. A., and Saudager, R. B., 2017, Co Processed Excipients for Tabletting: Review Artikel, Res J Pharm and Tech., 10 (7): 2427-2432
Atul, P., Subrata, K., and Ganga, S., 2013, A review on co-processed excipients: a novel approach in formulation development. IJRAPI., 3; 25-41
Bansal, A.K., and Nachaegari, S, K., 2004, Co processed excipient for solid dosage form. Pharm Technol., 2; 52-64.
Bin, L. K., Gaurav, A., and Mandal, U. K., 2019, A Review on Co-Processed Excipients: Current and Future Trend of Excipient Technology, Int J Pharm Pharm Sci., 11 (1); 1-9.
Bolhuis, G. K., Veen, B., Wu, Y. S., Zuuraman, K., and Frijlink, H. W., 2005, Compaction mechanism and tablet strength of unlubricated and lubricated silicified microcrystalline cellulose. Eur J Pharm Biopharm, 59:133-8.
Colorcon, 2020, Technical Bulletin: Starch 1500®, https://www.colorcon.com/ products-formulation/all-products/excipients/tablets/starch-1500/item/116-technical-bulletin-starch-1500, diakses tanggal 19 Agustus 2020.
DFE Pharmaa, 2020, Lactopress® Anhydrous, https://dfepharma.com/en/Excipients/ Expertise/Oral-Solid-Dose/Lactose/Anhydrous/Lactopress-Anhydrous#, diakses tanggal 20 Agustus, 2020.
DFE Pharmab, 2020, SuperTab® 22AN, https://www.dfepharma.es/Excipients/ Expertise/Oral-Solid-Dose/Lactose/Anhydrous/SuperTab-22AN, diakses tanggal 20 Agustus, 2020.
Desai, U., Chavan, R., Mhatre, P., and Chinchole, R., 2012, A Review: Coprocessed Excipients, Int J Pharm Sci Rev and Res., 12, (2); 93-105
Franc, A., Vetchý, D., Vodáčková, P., Kubaľák, R., Jendryková, L., Goněc, R., 2018, Co-processed excipients for direct compression of tablets, Čes. slov. Farm. 67; 175–181
Galbraith, S.C., Cha, B., Huang, Z., ,Park, S., Liu, H., Meyer, R.F., Flamm, M.H., Hurley, S., Zhang-Plasket, F., and Yoon, S., 2019, Integrated modeling of a continuous direct compression tablet manufacturing process: A production scale case study, Powder Technology, 354; 199–210.
FMC, 2020, Product Overview: Avicel®, PH-102, PH-200, Error! Hyperlink reference not valid., diakses tanggal 20 Agustus 2020.
Fuji Chemical, 2020, F-Melt®, http://www.fujichemical.co.jp/english/medical/ medicine/f-melt/f-melt_brochure.pdf, diakses tanggal 20 Agustus 2020.
Gohel, M. C., 2005, A review of co-processed directly compressible excipients, J Pharm Pharmaceut Sci., 8 (1); 76-93.
Gohel, M. C., and Jogani, P. D., 2005, A review of co-processed directly compressible excipients. J Pharm Pharm Sci., 8; 76-93.
Hauschild, K., and Picker, K. M., 2004, Evaluation of a new co-processed compound based on lactose and maize starch for tablet formulation, AAPS Pharm Sci., 6 :1-12.
JRS Pharma, 2020, VIVAPUR®, The High Quality MCC with Reduced Carbon Footprint, https://www.jrspharma.com/pharma_en/products-services/excipients/binders /vivapur.php, diakses tanggal 20 Agustus 2020
Lan, Y., 2008, A New Excipient for Fast Disintegrating Oral Dosage Forms, Pharma Ingredients & Services, BASF
McCormick, D., 2005, Evolutions in Direct Compression, Pharmaceutical Technology, April, 52 – 62.
Mamatha, B., Srilatha, D., Sivanarayani1, C. H., Prasanna K. D., and Rao, P. V., 2017, CO-Processed Excipients: An Overview, World J Pharm Res., 6 (15); 224-237
Meggle, 2020, https://www.meggle-pharma.com/en/downloads.html, diakses tanggal 17 Agustus 2020.
Michoel, A., and Rombaut, P., 2002, Comparative evaluation of co-processed lactose and microcrystalline cellulose with their physical mixtures in the formulation of folic acid tablets, Pharm Dev Technol., 7; 79-87.
Mullick, S., Sa, B., and Bandyopadhyay, A. K., 1992, Development of Some New Direct-Compression Carriers from Indigenous Starches for Tablet Compression, Indian Drugs, 29; 676-679.
Nagendrakumar, D., Raju, S. A., Shirsand, S. B., and Para, M. S., 2009, Design of fast dissolving granisetron HCL tablets using novel coprocessed superdisintegrants, J Biosci Technol., 1; 8-14.
Nofrerias, I., Nardi, A., Suñé-Pou, M., Suñé-Negre, J. M., García-Montoya, E., Pérez-Lozano, P., Ticó, J. R., and Miñarro, M., 2019, Comparison between Microcrystalline Celluloses of different gradesmade by four manufacturers using the SeDeM diagram expert system asa pharmaceutical characterization tool, Powder Technology, 342; 780–788
Pharmapproach, 2020, Direct Compression Excipients: Properties and Uses, March 26, 2020 in Pharmaceutical Technology, https://www.pharmapproach.com/direct-compression-excipients-properties-uses/ diakses tanggal 17 Agustus 2020.
Pharma Tips, 2020, Introduction of Tablet Manufacturing Process, Error! Hyperlink reference not valid. -Process. aspx,diakses tanggal 19 Agustus 2020.
Qiu, Y., Chen, Y., and Zhang, G. G. Z., 2009. Developing Oral Dosage Forms; Pharmaceutical Theory and Practice, Elsevier Inc. New York, USA. p.117-118,
Rojas, J., and Kumar, V., 2011, Comparative evaluation of silicified microcrystalline cellulose as a direct compression vehicle, Int J Pharm. 416 (1); 120-128
Satish, K. N., and Arvind, K. B., 2004, Coprocessed Excipients for Solid Dosage Forms, Pharmaceutical Technology, Januari, 52-64
Saiga, l. N., Baboota, S., Ahuja, A., and Ali, J., 2009., Microcrystalline Cellulose as a Versatile Excipient in Drug Research, J Young Pharm, 1; 6-12
Sheskey, P. J., Cook, W. G., and Cable, C. G., 2017, Handbook of Pharmaceutical Excipients, Pharmaceutical Press, The Royal Phramaceutical Society of Great Britain, p. 138-152; 505-527.
SPI Pharma, 2020, BARCROFT™ CS90 Directly Compressible Calcium Carbonate, https://www.spipharma.com/media/2436/cs90-calcium-carbonate-eu-sds.pdf, diakses tanggal 21 Agustus 2020.
Steele, D. F., Tobyn, M., Edge, S., Chen, A., and Staniforth, J. N. 2004., Physicochemical and mechanical evaluation of a novel high density grade of silicified microcrystalline cellulose, Drug Dev. Ind. Pharm., 30; 103–109
Sulaiman, T. N. S., 2007, Teknologi dan Formulasi Sediaan Tablet, Cetakan I, Pustaka Laboratorium Teknologi Farmasi Fakultas Farmasi Universitas Gadjah Mada, Yogyakarta. P. 20-21.
Thulluru, A., Madhavi, C., Nandini, K., Sirisha, S., and Spandana, D., 2019., Co-Processed Excipients: New Era in Pharmaceuticals, Asian J. Res. Pharm. Sci. 9(1): 01-05.
USP-NF, 2018, The United States Pharmacopeia and the National Formulary, USP 41–NF 36, The United States Pharmacopeial Convention, Rockville, USA p.7011
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.